Future Fields is a biotechnology company that produces recombinant proteins at scale, focusing on difficult-to-express proteins and high-quality recombinant proteins.

Future Fields

Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngine™, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science. 

Future Fields is a proud business member of 1% for the Planet, a global organization that accelerates smart environmental giving. We are also a part of the United Nations Global Compact initiative, committing to aligning strategies and operations with universal principles on human rights, labor, environment and anti-corruption, and taking actions that advance societal goals.

Learn more about how we’re transforming science for the future at https://futurefields.io/.

Sustainable Development Technology Canada

Y Combinator

Bossanova Investimentos

Pioneer Fund

Coughdrop Capital

Bee Partners

Narrative Fund

GROW Agrifoodtech Accelerator

Siddhi Capital

Toyota Ventures

Amplify Capital

Builders VC

Climate Capital

AgFunder

Green Circle Foodtech Ventures

Milad Alucozai

Inter-leukin' good! 👀📸 

We’re jazzed about our #interleukin going out the door yesterday. #IL2 is the beginning of more exciting launches to come. 🙌

View our IL-2 here 👉 https://bit.ly/4d6r9tV

YEG Deeptech Summer Shindig was for the books 😎☀️

We beat the heat last week with some pretty cool lab tours, ice cream making, and swapping stories of building a deeptech startup in Edmonton. 🚀

Thanks for inviting us out, G2V Optics Inc., Zero Point Cryogenics!

#YEG #deeptech #yegtech #yegstartup

Great to receive growth factors from our friends at Future Fields as part of our automated biomanufacturing Canada-Innovate UK grant.   It has never made sense to us that growth factors are added to cell culture, sporadically, in large excess.  I mean, we understand why.  Humans don't tend to want to do media changes at 2 am.  But science, in the case of cells, really does not sleep.  However, neither do Emmet and Marty.  Who can helpfully perform temperature-controlled media/growth factor exchanges automatically whenever you want.  Helping scientists get some well-needed rest, designing better experiments, mirroring more closely physiologically operating biological systems, and then seamlessly scaling straight to production too.  Check out our web pages if you want to know more.  Plus, we like a good bit of merch, particularly pin badges 😀.

#stemcells #biomanufacturing #automation #researchanddevelopment

Product compliance goes beyond the lab - we ensure our products are in line with government regulations. Our regulatory experts are here to answer any questions you may have! 🙌

Learn more about quality at Future Fields 👉: https://bit.ly/4dG9zxu

Every lab talks about reliability -  but what does it actually look like? 🥼🔍

Our QC team conducts in-process testing at critical control points to ensure batch-to-batch consistency. 🔁

Finished product testing involves various analytical techniques, which are detailed on each Product Data Sheet.

Learn more about quality at Future Fields 👉 https://bit.ly/4fA0xUk

"How do I reconstitute my lyophilized recombinant protein?"

This is a common question we get from our customers. Paige, Senior Research Scientist from our Protein Biochemistry team walks us through the reconstitution process. 👩🔬

Watch below 👇

Exciting new research from Sorbonne Université shows IL-2 has potential therapeutic potential for multiple sclerosis! 🙌

Multiple sclerosis is an autoimmune disease that attacks nerve myelin of the brain and spine. 🧠 Studies found that providing low doses of IL-2 activated regulatory T cells reduced the activity of multiple sclerosis disease.

Read the publication:
https://bit.ly/4dxsxGj

#IL2 #Tregs #multiplesclerosis

Quality is upheld by every Future Fielder, but we can thank our Quality Assurance (QA) team for keeping us in check. ✅

QA leads our document management system and oversees manufacturing activities to ensure consistent product quality. 🙌

Learn more about quality at Future Fields 👉 https://bit.ly/46jvb01

Lots of fun finds from our ABC Swap last week! 👕🔁

Our Sustainability Committee hosted a team ABC (Appliances 📻, Boredom Busters 📚, Clothing 👗) Swap event to promote a circular economy and eco-friendly values in an engaging way.

We exchanged useful gadgets and toys, picked up new books, and gave new life to formerly loved garments—any remaining items are being saved for donation.

Shoutout to the Sustainability Committee for bringing us together in a meaningful way. Here's to more sustainable initiatives and fun in the future! ♻️

In case you missed it - we launched a new protein last week. 👀🩵

Part of the IL (Interleukin) Superfamily 🦸, IL-2 plays a significant role in growing T cells. 

Bioactive, high in purity, and excelling in safety, what makes this recombinant #IL2 unique is that it's made by transgenic fruit flies 🪰 in our Green-certified lab. 🥼

Request a free sample for your research 👇 https://bit.ly/4bQKBKe

news impact assignment basic	general
public peers	general	Aug 31, 2024 11:25 AM	5039581b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 31, 2024 11:25 AM	7f03b724
translate crunchbase fundingrounds	general
peers	general	Aug 31, 2024 11:25 AM	06ee60de
news basic	general	Aug 31, 2024 11:25 AM	1c3815a8
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

IO:FUTUREFIELDS

Future Fields